Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

36 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Eligibility DRKS00005163 NCT01207388 B-ALL - Eligibility

- 27/9/21 - 1 formulario, 2 itemgroups, 14 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01207388

Eligibility DRKS00003796 NCT01209286 B-ALL - Eligibility

- 27/9/21 - 1 formulario, 2 itemgroups, 15 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01209286

Eligibility Leukemia, Lymphocytic NCT00313079

- 20/9/21 - 1 formulario, 2 itemgroups, 35 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00313079

Eligibility NCT01195480 Acute Lymphoblastic Leukemia - Eligibility

- 20/9/21 - 1 formulario, 2 itemgroups, 28 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT01195480

Eligibility Leukemia NCT00452439

- 2/9/21 - 1 formulario, 2 itemgroups, 13 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of Actonel for the Prevention of Bone Loss; ODM derived from: https://clinicaltrials.gov/show/NCT00452439

Eligibility Lymphoblastic Leukemia, Acute T-cell NCT01363817

- 11/7/20 - 1 formulario, 3 itemgroups, 10 items, 1 idioma
Itemgroups: Criteria, Inclusion Criteria, Exclusion Criteria
Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01363817

Eligibility B-cell Adult Acute Lymphoblastic Leukemia NCT00866307

- 18/8/19 - 1 formulario, 2 itemgroups, 14 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011); ODM derived from: https://clinicaltrials.gov/show/NCT00866307

Eligibility Leukemia, Lymphoblastic, Acute NCT02264873

- 27/4/19 - 1 formulario, 2 itemgroups, 15 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Phase I, Dose Escalation Study of Decitabine; ODM derived from: https://clinicaltrials.gov/show/NCT02264873

Eligibility Lymphoid Leukemia NCT00801580

- 29/5/18 - 1 formulario, 2 itemgroups, 19 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00801580

Eligibility Lymphoblastic Leukemia, Acute NCT00995137

- 28/5/18 - 1 formulario, 2 itemgroups, 18 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00995137

Eligibility Leukemia, Lymphocytic, Acute NCT00548431

- 23/5/18 - 1 formulario, 2 itemgroups, 9 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00548431

Eligibility Leukemia NCT01016379

- 22/5/18 - 1 formulario, 1 itemgroup, 9 items, 1 idioma
Itemgroup: Criteria
Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01016379

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial